PE

Peijia Medical LtdOOTC PEJMF Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

0.277

Micro

Exchange

OOTC - OTC

PEJMF Stock Analysis

PE

Uncovered

Peijia Medical Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-20/100

Low score

Market cap $B

0.277

Dividend yield

Shares outstanding

672.67 B

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu and currently employs 807 full-time employees. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

View Section: Eyestock Rating